GoodRx Holdings (GDRX) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -257.1 | 48.0 | 65.2 | 68.5 | 108.8 | 146.0 | ||
| Changes by years, y/y, % | -273% | -119% | +36% | +5% | +59% | +4.5% | |||
GoodRx Holdings. EBITDA US GAAP, bln rub
GoodRx Holdings. EBITDA US GAAP, changes, %
GoodRx Holdings. EBITDA US GAAP, sum by quarters, bln rub
GoodRx Holdings (GDRX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -5.31 | 34.9 | 36.3 | 36.8 | 38.0 | 146.0 | |
| Changes by years, y/y, % | -558% | +54% | +15% | -13% | -816% | |||
| Changes by quarters, q/q, % | -113% | -757% | +4% | +1% | +3% | |||